Plant Based Extracts and Cognition

NCT ID: NCT02202629

Last Updated: 2014-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute, randomized, placebo controlled, double blind, 4 arm crossover study to determine the effect of different combinations of plant based extracts on cognitive function and cerebral blood flow.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of this study are to assess the effects of oral consumption of three differing combinations of plant based extracts, on cognitive function and cerebral blood flow (using Near infrared Spectroscopy) in comparison to placebo. The primary outcome will be change in cognitive function and mental fatigue during extended performance of the Cognitive Demand Battery (CDB) at 1, 3 and 6 hours post- consumption.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Change in Cognitive Function and Fatigue During Extended Performance of the Cognitive Demand Battery (CDB) at 1, 3 and 6 Hours Post Consumption Change in Long Term Declarative Memory at 1, 3 and 6 Hours Post-intervention.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cherry flavoured beverage 1

10floz cherry flavoured test article

Group Type PLACEBO_COMPARATOR

No interventions assigned to this group

Cherry flavoured beverage 2

10floz of cherry flavoured test article with fruit, vegetable and herbal extracts

Group Type EXPERIMENTAL

Beverage containing plant based extracts

Intervention Type OTHER

Intervention involves single exposure, oral consumption of test article following baseline measurements

Cherry flavoured beverage 3

10floz of cherry flavoured test article with fruit, vegetable and herbal extracts

Group Type EXPERIMENTAL

Beverage containing plant based extracts

Intervention Type OTHER

Intervention involves single exposure, oral consumption of test article following baseline measurements

Cherry flavoured beverage 4

10floz of cherry flavoured test article with fruit, vegetable and herbal extracts

Group Type EXPERIMENTAL

Beverage containing plant based extracts

Intervention Type OTHER

Intervention involves single exposure, oral consumption of test article following baseline measurements

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Beverage containing plant based extracts

Intervention involves single exposure, oral consumption of test article following baseline measurements

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Are over 18 or under 49 years of age
* Self-report of good health

Exclusion Criteria

* English is first language (some of the cognitive tests have only been validated in native English speakers)


* Are below 18 or above 49 years of age
* Are a smoker
* Have food allergies or sensitivities to any of the ingredients contained in the investigational product or any other foodstuff
* Currently take medication except the contraceptive pill
* Have habitually used dietary supplements within the last month (defined as more than 3 consecutive days or 4 days in total)
* Have sleep disturbances and/or are taking sleep aid medication
* Have a Body Mass Index (BMI) outside of the range 18-35 kg/m2
* Have high blood pressure (systolic over 139 mm Hg or diastolic over 89 mm Hg)
* Have a history of neurological, vascular or psychiatric illness including epilepsy or seizures (excluding depressive illness and anxiety)
* Have a current diagnosis of anxiety or depression
* Are pregnant, trying to get pregnant or breast feeding
* Have a recent history of (within 12 months of screening visit) or strong potential for alcohol or substance abuse. Alcohol abuse is defined as more than 60g (men) / 40g (women) pure alcohol per day (7 / 5.5 units)
* Are (or are seeking to become) pregnant or are lactating
* Have learning difficulties, dyslexia or colour blindness
* Have visual impairment that cannot be corrected with glasses or contact lenses
* Have frequent migraines that require medication (more than or equal to 1 per month)
* Have disorders of the blood
* Have a heart disorder or a history of vascular illness
* Have a respiratory disorder that requires regular medication (Note: participants with asthma who only take their medication occasionally/as required are eligible for this study)
* Have type I or type II diabetes
* Have a history of renal or hepatic disease, or other severe diseases of the gastrointestinal tract (e.g. iron accumulation, iron utilization disorders, hypercalcaemia, hypercalciuria), that are likely to interfere with metabolism/absorption/secretion of the product under investigation
* Have any health condition that would prevent fulfillment of the study requirements
* Are currently or have in the past 4 weeks participated in other clinical or nutrition intervention studies
* Do not have a bank account (required for payment)
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PepsiCo Global R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northumbria University

Newcastle upon Tyne, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Kennedy, PhD

Role: CONTACT

Philippa Jackson

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEP-1406

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nutrient-Fortified Beverage Study
NCT02103192 COMPLETED NA